Joshua Rosen - Aug 23, 2024 Form 4 Insider Report for Vireo Growth Inc. (VREOF)

Role
CEO and Interim CFO, Director
Signature
/s/ Amber Shimpa, Attorney-in-Fact for Joshua Rosen
Stock symbol
VREOF
Transactions as of
Aug 23, 2024
Transactions value $
$0
Form type
4
Date filed
10/11/2024, 04:26 PM
Previous filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VREOF Subordinate Voting Shares Award $0 +500K $0.00 500K Oct 10, 2024 Direct F1
holding VREOF Subordinate Voting Shares 730K Aug 23, 2024 By Bengal Catalyst Fund LP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VREOF Stock Option (right to buy) Award $0 +250K $0.00 250K Aug 23, 2024 Subordinate Voting Shares 250K $0.47 Direct F3
transaction VREOF Stock Option (right to buy) Award $0 +500K $0.00 500K Oct 9, 2024 Subordinate Voting Shares 500K $0.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Joshua Rosen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Mr. Rosen in connection with his Separation Agreement with the Company. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and vest in 12 equal installments commencing January 1, 2025 and ending on December 1, 2025.
F2 Shares owned by Bengal Catalyst Fund LP. As Managing Partner of Bengal Capital, Mr. Rosen has shared voting control over these shares.
F3 Vests in tranches of 62,500 options upon the first, second, third and fourth anniversary dates following the grant date.